Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | lysine (K)-specific methyltransferase 2A | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K09188 myeloid/lymphoid or mixed-lineage leukemia protein 3, putative | Get druggable targets OG5_130642 | All targets in OG5_130642 |
Neospora caninum | Multidomain chromatinic protein with the following architecture: 3x PHD-bromo-3xPHD-SET domain and associated cysteine cluster a | Get druggable targets OG5_130642 | All targets in OG5_130642 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | Get druggable targets OG5_130642 | All targets in OG5_130642 |
Toxoplasma gondii | histone lysine methyltransferase SET1 | Get druggable targets OG5_130642 | All targets in OG5_130642 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Toxoplasma gondii | histone lysine methyltransferase SET1 | 0.0066 | 0.5423 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Echinococcus multilocularis | tar DNA binding protein | 0.0062 | 0.5137 | 1 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0398 | 0.0109 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0584 | 0.0498 |
Trichomonas vaginalis | helicase, putative | 0.0008 | 0.0331 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0008 | 0.0346 | 0.0316 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0005 | 0.0078 | 0.0127 |
Loa Loa (eye worm) | Smad1 | 0.0008 | 0.0346 | 0.0316 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0346 | 0.0566 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.5137 | 0.8402 |
Echinococcus granulosus | mixed lineage leukemia protein mll | 0.0009 | 0.0398 | 0.0109 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.2866 | 0.4688 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Echinococcus multilocularis | mixed lineage leukemia protein mll | 0.0009 | 0.0398 | 0.0109 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0346 | 0.0316 |
Schistosoma mansoni | cpg binding protein | 0.0037 | 0.2866 | 0.4688 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0118 | 1 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | smad | 0.0008 | 0.0346 | 0.0566 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0346 | 0.0566 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.5137 | 0.8402 |
Brugia malayi | MH2 domain containing protein | 0.0008 | 0.0346 | 0.0316 |
Schistosoma mansoni | smad1 5 8 and | 0.0008 | 0.0346 | 0.0566 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0331 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0118 | 1 | 1 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0062 | 0.5137 | 0.5122 |
Loa Loa (eye worm) | RNA binding protein | 0.0062 | 0.5137 | 0.5122 |
Echinococcus multilocularis | cpg binding protein | 0.0037 | 0.2866 | 0.526 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.5137 | 0.8402 |
Echinococcus multilocularis | histone lysine N methyltransferase MLL3 | 0.0011 | 0.0584 | 0.0498 |
Brugia malayi | CXXC zinc finger family protein | 0.0035 | 0.2692 | 0.267 |
Loa Loa (eye worm) | CXXC zinc finger family protein | 0.0035 | 0.2692 | 0.267 |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0346 | 0.0316 |
Echinococcus granulosus | histone lysine N methyltransferase MLL3 | 0.0009 | 0.0398 | 0.0109 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.5137 | 0.8402 |
Brugia malayi | RNA binding protein | 0.0062 | 0.5137 | 0.5122 |
Brugia malayi | Smad1 | 0.0008 | 0.0346 | 0.0316 |
Trichomonas vaginalis | chromodomain-helicase-DNA-binding protein, putative | 0.0008 | 0.0331 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Loa Loa (eye worm) | histone methyltransferase | 0.0011 | 0.0584 | 0.0556 |
Schistosoma mansoni | Smad4 | 0.0008 | 0.0346 | 0.0566 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Brugia malayi | F/Y-rich N-terminus family protein | 0.0011 | 0.0572 | 0.0544 |
Onchocerca volvulus | 0.0035 | 0.2692 | 0.5 | |
Brugia malayi | MH1 domain containing protein | 0.0008 | 0.0346 | 0.0316 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0009 | 0.0398 | 0.0651 |
Echinococcus granulosus | tar DNA binding protein | 0.0062 | 0.5137 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | tar DNA-binding protein | 0.0062 | 0.5137 | 0.8402 |
Echinococcus granulosus | cpg binding protein | 0.0037 | 0.2866 | 0.526 |
Plasmodium falciparum | zinc finger protein, putative | 0.0004 | 0 | 0.5 |
Schistosoma mansoni | mixed-lineage leukemia protein mll | 0.0074 | 0.6114 | 1 |
Brugia malayi | TAR-binding protein | 0.0062 | 0.5137 | 0.5122 |
Entamoeba histolytica | hypothetical protein | 0.0004 | 0 | 0.5 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Trichomonas vaginalis | chromodomain helicase DNA binding protein, putative | 0.0008 | 0.0331 | 1 |
Schistosoma mansoni | TGF-beta signal transducer Smad2 | 0.0008 | 0.0346 | 0.0566 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0062 | 0.5137 | 0.5122 |
Loa Loa (eye worm) | TAR-binding protein | 0.0062 | 0.5137 | 0.5122 |
Schistosoma mansoni | cpg binding protein | 0.0035 | 0.2692 | 0.4403 |
Loa Loa (eye worm) | MH1 domain-containing protein | 0.0008 | 0.0346 | 0.0316 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 1.4125 um | PUBCHEM_BIOASSAY: qHTS Fluorescence Polarization Assay for Inhibitors of MLL CXXC domain - DNA interaction. (Class of assay: confirmatory) [Related pubchem assays: 2698 (Summary assay.)] | ChEMBL. | No reference |
Potency (functional) | = 3.1623 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 6.5733 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 48 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of BAZ2B. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504391] | ChEMBL. | No reference |
Potency (functional) | = 39.8107 um | PUBCHEM_BIOASSAY: qHTS Assay for Identifying a Potential Treatment of Ataxia-Telangiectasia. (Class of assay: confirmatory) | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.